Multifaceted Role of RNA Editing in Promoting Loss-of-function of PODXL in Cancer
Overview
Affiliations
PODXL, a protein that is dysregulated in multiple cancers, plays an important role in promoting cancer metastasis. In this study, we report that RNA editing promotes the inclusion of a alternative exon. The resulting edited PODXL long isoform is more prone to protease digestion and has the strongest effects on reducing cell migration and cisplatin chemoresistance among the three PODXL isoforms (short, unedited long, and edited long isoforms). Importantly, the editing level of the recoding site and the inclusion level of the alternative exon are strongly associated with overall patient survival in Kidney Renal Clear Cell Carcinoma (KIRC). Supported by significant enrichment of exonic RNA editing sites in alternatively spliced exons, we hypothesize that exonic RNA editing sites may enhance proteomic diversity through alternative splicing, in addition to amino acid changes, a previously under-appreciated aspect of RNA editing function.
ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer.
Bernal Y, Duran E, Solar I, Sagredo E, Armisen R Int J Mol Sci. 2024; 25(13).
PMID: 39000531 PMC: 11242177. DOI: 10.3390/ijms25137424.
RNA Editing in Cancer Progression.
Frezza V, Chellini L, Del Verme A, Paronetto M Cancers (Basel). 2023; 15(21).
PMID: 37958449 PMC: 10648226. DOI: 10.3390/cancers15215277.